GRWRHITECH — Deck

Garware Hi-Tech Films Limited · GRWRHITECH · BSE / NSE

Specialty-films compounder priced like it already won while a 50% US tariff eats the growth story

₹3,986
Price
₹9,260 Cr
Market cap
30×
P/E (TTM)
21%
FY25 op margin
₹2,500 Cr FY26 guide withdrawn · Q3 FY26 OPM 15% · ₹669 Cr net cash · 60.73% promoter, zero pledge
1 · What this is

A family-owned BOPET exporter quietly rebuilt as a specialty consumer-films brand.

  • Business model. Buys PTA + MEG, polymerizes to PET chips, extrudes base film, then coats and laminates it into Sun Control Film and Paint Protection Film sold under owned brands into 90+ countries. 71% of revenue is the Consumer Products Division at ~25% EBITDA margin; 29% is a commodity Industrial Division that just lowers the cost base.
  • Competitive position. The only Indian polyester-films peer earning 21% ROCE — Polyplex, Jindal Poly and Ester cluster at 5–9%. The moat is vertical integration paired with 250+ Garware Application Studios, 1,000+ trained applicators, and proprietary deep-dye technology; PPF/SCF unit prices are 4–10× the underlying chip, so chip-spread shocks halve peer margins but barely dent Garware's.
  • What's changed. Value-added mix went from 28% of revenue in FY17 to 87% in FY25; the corporate rename from Garware Polyester to Garware Hi-Tech Films in May 2021 put a label on the pivot. Paint Protection Film capacity doubled to 600 LSF on 24-Sep-2025, and a ₹118 Cr TPU backward-integration line is locked for Oct-2026.
Two businesses inside one P&L — the consumer brand is the thesis, the industrial book is the cost spine that makes it cheaper.
2 · Money picture

Decade-long margin re-rating is real — but Q3 FY26 just cracked the 20% floor the multiple depends on.

₹2,109 Cr
Revenue FY25 +26% YoY
21.0%
Op margin FY25 (vs 8% FY17)
20.6%
ROCE FY25 (vs 5% FY17)
₹669 Cr
Net cash zero debt FY25

Revenue nearly doubled in five years (₹925 Cr → ₹2,109 Cr) while PAT quadrupled to ₹331 Cr — the engine is mix, not volume. EPS compounded 31% for five years on unchanged share count, and FY24 wiped out debt entirely. The crack in the story is Q3 FY26: revenue ₹459 Cr (-1.6% YoY), operating margin 15% — the lowest print in 14 quarters and the first evidence that a full 50% US tariff costs real margin, not just optics.

3 · Price picture

Range-bound near mid-range while the tape waits for the Q4 print.

  • Trend. ₹4,005 close on 17-Apr-2026 sits mid-band in a 52-week range of ₹2,681–₹4,800; the stock is a 7.5× since Mar-2023 and a 53% 1-year return, but has chopped ₹1,000-wide between every quarterly print for four quarters.
  • Relative strength. Institutional discovery is the real signal: FII stake climbed from 0.18% (Mar-23) to 3.96% (Dec-25), DIIs from 2.19% to 5.35%, and the shareholder count jumped from 32,022 to 55,544 — retail float is being absorbed by funds at rising prices. The 40% three-day rally after Q3 FY26 on heavy delivery volumes was the tell.
  • Key levels. Above ₹4,800 (June 2025 high) confirms the re-rating pillar held through the tariff shock; below ₹2,970 (Jan-2026 low on margin concern) re-opens the BOPET-peer multiple of 20–22×.
Consensus is an outlier: lone sell-side target ₹2,730 vs. ₹4,005 current — a -31% spread with one Sell rating and no Buy coverage.
4 · Who runs this

Clean balance sheet, family-held, and a governance structure built for the 1980s.

  • Ownership. Garware family holds 60.73%, flat to the second decimal for 12 consecutive quarters, zero pledge, no options, no dilution. No promoter selling since June 2019. Public float is being absorbed by LIC MF, JM Flexicap and Ashish Kacholia; institutional endorsement is accelerating.
  • Leadership. Chairman Dr. S. B. Garware is 89 and has run the business since 1957; three daughters serve as Joint MDs (aged 62+). No named non-family CEO candidate, no mentored successor. None of the four Garwares has attended any of the last 12 earnings calls — concalls are fronted by Deepak Joshi (non-board sales director) and the new CFO Abhishek Agarwal (Aug-2024).
  • Signal. Three promoter directors drew ₹37 Cr in FY25 (11% of standalone PAT; the Chairman alone earned 235× the median employee, with the Directors' Report headline understating his pay by ~80% versus Annexure II). A ₹50 Cr/year related-party processing contract with promoter-owned Garware Industries Pvt Ltd has run for a decade; management has twice refused to in-house it. Governance grade: C+.
5 · How it got here

From commodity polyester exporter to vertically integrated specialty-films brand — in two visible pivots.

The past: For 60 years this was Garware Polyester Limited, a BOPET exporter with revenue stuck in an ₹830–950 Cr band from FY14 through FY20 and single-digit operating margins. Chairman Dr. S. B. Garware started the polyester film industry in India in 1957; the company's identity was plain BOPET film sold to global converters.

The pivot: The Paint Protection Film line at Waluj went live in Q4 FY21, the second lamination line followed, and in May 2021 the company rebranded to Garware Hi-Tech Films — the label on a four-year mix-shift that was already running. Value-added mix went from 28% (FY17) to 82% (FY24) to 87% (FY25); ROCE tripled from 5% to 21%; market cap went 7.5× in two years to ₹9,145 Cr. Management issued its first-ever hard guidance — ₹2,500 Cr FY26, 20–25% CAGR — in May 2025.

Today: The FY26 guidance was withdrawn after US tariffs stacked from 16% to 50% between April and August 2025; 9M FY26 revenue is ₹1,523 Cr, tracking ~17% below promise. The new chapters — a UAE subsidiary for MENA, a Chembur D2C flagship for Garware Home Solutions, and a ₹118 Cr TPU line for Oct-2026 — answer a simpler question than the old one: how much margin survives if 40% of revenue stays under a 50% tariff for a year?

The pivot is already done; the test now is whether the pivoted business can absorb a geopolitical shock without the multiple following margin down.
6 · What's happening now

Tariff shock absorbed once — the question is whether Q4 FY26 proves it was mix or just one-off gymnastics.

  • Recent event. On 8-Feb-2026 Garware reported Q3 FY26 revenue ₹459 Cr (-1.6% YoY) and EBITDA ₹70 Cr (-13% YoY), OPM 15% — the lowest in 14 quarters, printed under the full 50% US tariff. Management claims ₹40 Cr of a ~₹50 Cr headline tariff hit was neutralised through mix shift, MENA/EU diversion, and bonded-warehouse timing.
  • Market view. The stock rallied +40% in three trading days post-print on heavy delivery volumes despite the margin miss — the market read the PPF-line-live confirmation and TPU lock-in as more important than the tariff drag. But sell-side coverage is thin and one-sided: a single published target of ₹2,730 (MarketsMOJO at Sell), -31% below current, with no Buy-side broker targets in the tape.
  • Off-filing signal. Management withdrew the ₹2,500 Cr FY26 guide rather than lower it — the first real miss after six calls of reaffirmation. US bonded-warehouse inventory is sitting at ~100 days vs a normal 60–75, waiting on a tariff rollback; Middle East revenue has doubled to 8% in one year, and the Mumbai flagship Garware Home Solutions studio opened during Q3.
The +40% three-day rally was the market pricing FY27+ — one more tariff quarter without a guidance reset unwinds it fast.
7 · What's next

One acute catalyst, two structural ones: the Q4 guidance reset, the TPU commissioning, and the tariff trajectory.

  • May 2026 — Q4 + FY26 earnings. Does management restate an FY27 revenue number and does operating margin recover above 20%? Both in the same release is the re-rating trigger; a second quarter of silence compresses the multiple toward the 20–22× it carried in FY23.
  • Ongoing — US tariff trajectory. 50% duty stepped up Aug-2025 covers ~40% of revenue. Any bilateral rollback directly re-opens earnings; persistence beyond FY27 idles the new 600 LSF PPF line and pushes the TPU payback out a year.
  • Oct 2026 — TPU extrusion line commissioning. ₹118 Cr first-of-its-kind-in-India plant completes chip-to-film backward integration for PPF; management guides +150–200 bps margin uplift at maturity. The commissioning date has already wandered once — delivery is itself a credibility test.
Q4 FY26 guidance reset is the one event the market is watching — everything else is a slow compound.
8 · For & against

Lean cautious — the specialty pivot is real, but 30× P/E is pricing the 20%+ margin as permanent in a quarter it just wasn't.

  • For. The margin gap is structural, not cyclical — Garware's 20.6% ROCE against Polyplex 7.2% and Jindal Poly 5.4% held through two full BOPET cycles; the FY24 collapse that cratered peers 14–24 points cost Garware 2 points.
  • For. Balance sheet is a fortress — ₹669 Cr net cash, zero debt, capex of ₹243 Cr across the PPF and TPU lines fully funded internally. In a tariff drawdown the company can absorb 3–4 quarters of US weakness, finish the build-out, and still hold the dividend without touching equity.
  • For. Q3 FY26 was the live stress test and the machine bent but didn't break — 50% tariff absorbed with a 2–4 point margin compression rather than the margin collapse a plain BOPET maker would have printed; Middle East doubled to 8% of revenue in a single year.
  • Against. The ₹2,500 Cr FY26 guide was reaffirmed across four quarters and then withdrawn — not restated. TTM revenue at ₹2,071 Cr is a ~17% miss on a repeated promise; the next number management gives will be weighed against that credibility event.
  • Against. 30× P/E requires a 20%+ margin to hold; Q3 FY26 printed 15% and the committed 25% ± 3% band was breached in the same fiscal year. The bear case (15% structural margin, 22× multiple on ~₹113 EPS) points to ~₹2,500 — a ~38% downside from ₹4,005.
  • Against. Governance is a C+ and it is fixable, but unfixed — ₹37 Cr of family pay (Chairman at 235× median employee), a ₹50 Cr/year related-party processing contract with a promoter-owned entity that management has refused to in-house for a decade, and no named CEO successor behind an 89-year-old Chairman.
My View — The For side has the better structural story; the Against side has the better near-term tape. The withdrawn FY26 guide is a credibility event that the multiple hasn't fully absorbed. A Q4 FY26 print with OPM back above 20% and a specific restated FY27 number — both in the same release — would flip the lean constructive.

Watchlist to re-rate: Watch: (1) Q4 FY26 margin print vs the 18.9% Q3 run-rate and whether FY27 guidance is reopened; (2) US tariff persistence or rollback, directly re-opening ~40% of revenue; (3) TPU line on-time commissioning in Oct 2026 as the next credibility test.